A new study from researchers at the Alliance for Clinical Trials in Oncology (Alliance) shows that patients with stage III ...

Baylor University researchers have developed a novel approach to fight colorectal cancer, using modified bacteria as a courier to deliver potent cancer-killing proteins into tumor cells. Michael S.

A Pfizer drug recently awarded accelerated FDA approval in colorectal cancer now has additional data showing it met key goals in its pivotal study, results that could support an application seeking ...

GLP-1s were linked to a lower death risk in colon cancer in a recent study. Image credit: ARMEND NIMANI/Getty Images “This means that, “in addition to lowering glucose [blood sugar] and weight, they ...

ROCHESTER, Minn. — A new treatment combining immunotherapy with chemotherapy after surgery cut the risk of cancer coming back ...

Region-specific biomarkers FGFR4, FLT1, and WNT5A are linked to tumor behavior and therapeutic response in CRC. Comprehensive genomic profiling (CGP) aids in precision medicine by identifying genetic ...

Eagan, Minnesota-based immune health company Biothera Inc. announced Wednesday that it has begun dosing patients for its phase 3 clinical trial to evaluate a new drug to treat late-stage colorectal ...

Add Yahoo as a preferred source to see more of our stories on Google. Ozempic can cost anywhere from over $1,000 to a $25, depending on how you pay for it.Peter Dazeley/Getty Images Colon cancer ...

CINCINNATI (WKRC) - A new study found a correlation between regular use of a popular over-the-counter drug and a decreased risk in certain types of cancer. The study, published in the Journal of ...